Gijtenbeek, Rolof G.P. et al
"Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI) versus intercalated TKI with chemotherapy for EGFR-mutated nonsmall cell lung cancer." ERJ Open Research
8.4
(2022):
00239-2022.
Web. 18 April. 2024.